Learn how Ab Initio is helping start-ups translate therapeutics to the clinic

Written By PY

Learn how Ab Initio is helping start-ups, entrepreneurs and innovators translate therapeutics and biotech to the clinic. Ab Initio provides state of the art formulation and manufacturing facilities for conventional dosage forms as well as specialising in niche drug delivery areas such as nasal and respiratory product development.

PY
Previous

Ab Initio's Chief Scientific Officer recognised for significant accomplishments within the field
Next

Ab Initio appoints new COO & Head of Manufacturing